Lung Cancer Screening in the US, 2022
JAMA Internal Medicine Author Interviews
00:00
Disparities in Lung Cancer Screening Rates Across the US
This chapter provides an in-depth look at lung cancer screening rates across the United States in 2022, exposing significant disparities influenced by healthcare access and demographics. It also explores the disconnect between screening rates and lung cancer mortality, while highlighting the role of Medicaid expansion in improving screening accessibility.
Play episode from 05:03
Transcript


